Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Receivables for the year ending December 31, 2023: USD 18.09 M

Lifecome Biochemistry Co.,Ltd. Receivables is USD 18.09 M for the year ending December 31, 2023, a 98.70% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Lifecome Biochemistry Co.,Ltd. Receivables for the year ending December 31, 2022 was USD 9.10 M, a 28.95% change year over year.
Lifecome Biochemistry Co.,Ltd. Receivables for the year ending December 31, 2021 was USD 7.06 M, a 35.04% change year over year.
Lifecome Biochemistry Co.,Ltd. Receivables for the year ending December 31, 2020 was USD 5.23 M, a -62.58% change year over year.
Lifecome Biochemistry Co.,Ltd. Receivables for the year ending December 31, 2019 was USD 13.97 M, a 68.40% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years